‘BMI does not tell the whole story in MASLD’; body roundness might
NASHVILLE, Tenn. — Body roundness index may improve mortality risk stratification in metabolic dysfunction-associated steatotic liver disease, identifying high-risk lean and nonobese individuals often overlooked by BMI.
Findings presented at ACG Annual Scientific Meeting indicated that, although BMI remains a useful measure of overall body size and obesity, complementing with body roundness index may help capture body shape and central adiposity risk factors that BMI alone may miss.
“We often use BMI as a shorthand for obesity and metabolic risk, yet we see patients with MASLD who have a normal